Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
08-Sep-2025 | 781.55 | 813 | 778.2 | 787 | 26,598 | 48,34,51,979.85 | 2,59,666 |
09-Sep-2025 | 789 | 799.05 | 765 | 784.2 | 29,088 | 54,53,96,958.55 | 2,85,185 |
10-Sep-2025 | 785 | 806 | 780.7 | 798.05 | 26,973 | 38,90,10,415.5 | 2,44,098 |
11-Sep-2025 | 800.4 | 809.55 | 790.7 | 798.9 | 16,454 | 29,23,82,945.35 | 1,47,592 |
12-Sep-2025 | 798 | 806.9 | 767.55 | 770.25 | 27,572 | 52,95,34,530.15 | 3,73,387 |
15-Sep-2025 | 775 | 819.95 | 775 | 801.75 | 37,015 | 92,57,02,036.05 | 4,43,529 |
16-Sep-2025 | 807.6 | 808 | 775 | 784.95 | 27,107 | 60,57,30,944.6 | 4,03,563 |
17-Sep-2025 | 789 | 804.95 | 785.45 | 799.8 | 22,497 | 39,16,07,029.1 | 2,24,290 |
18-Sep-2025 | 802.05 | 804.6 | 786 | 789.25 | 8,897 | 14,04,50,027.1 | 82,010 |
19-Sep-2025 | 789.6 | 795 | 771.05 | 776.45 | 13,476 | 22,96,74,888.65 | 1,56,778 |
22-Sep-2025 | 777.45 | 788.65 | 771 | 774.25 | 17,585 | 19,67,40,570 | 1,10,515 |
23-Sep-2025 | 780 | 792.65 | 777 | 784.55 | 25,598 | 32,97,05,418.55 | 2,33,864 |
24-Sep-2025 | 783.85 | 796.35 | 777.2 | 784.95 | 28,627 | 33,91,86,534.35 | 2,23,441 |
25-Sep-2025 | 784.9 | 794.25 | 777.1 | 781 | 16,427 | 22,03,40,323.6 | 1,21,421 |
26-Sep-2025 | 781 | 799 | 773.2 | 781.35 | 25,351 | 37,81,24,849.7 | 2,39,542 |
29-Sep-2025 | 782.75 | 784.15 | 746.45 | 750 | 32,275 | 47,27,23,237.8 | 2,81,838 |
30-Sep-2025 | 750.2 | 761 | 737.55 | 741.2 | 15,957 | 27,08,72,216.8 | 1,80,356 |
01-Oct-2025 | 742 | 760.55 | 741.55 | 749.95 | 11,672 | 16,36,12,896.25 | 1,15,594 |
03-Oct-2025 | 749.95 | 752.8 | 733.25 | 745 | 19,413 | 26,79,44,629 | 1,71,543 |
06-Oct-2025 | 776 | 785.05 | 755.65 | 781.7 | 47,440 | 1,05,16,98,782.9 | 4,37,412 |
The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
